Skip to main content
 
Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

See our updated masking policy

Stanford Health Care

Does perfusion mismatch modify the benefit of thrombectomy in large core stroke? A meta-analysis of trials.

Does perfusion mismatch modify the benefit of thrombectomy in large core stroke? A meta-analysis of trials. Journal of neurointerventional surgery Ter Schiphorst, A., Arquizan, C., Labreuche, J., Turc, G., Yuen, N., Mlynash, M., Lansberg, M. G., Heit, J. J., Lapergue, B., Henon, H., Nouri, N., Albucher, J. F., Cognard, C., Marnat, G., Sibon, I., Jovin, T. G., Olivot, J., Albers, G. W., Costalat, V. 2025

Abstract

BACKGROUND: Whether perfusion 'mismatch' modifies the effect of endovascular thrombectomy (EVT) in patients with large core ischemic stroke remains uncertain.METHODS: We conducted a Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA)-compliant systematic review and meta-analysis of randomized controlled trials (RCTs) enrolling patients with large infarcts and reporting outcomes by perfusion mismatch status, defined as a mismatch ratio =1.2and a mismatch volume =10mL. A Mantel-Haenszel fixed-effect model was used to pool ORs for three 90-day outcomes: independent ambulation (modified Rankin Scale (mRS) score 0-3, primary outcome), good outcome (mRS score 0-2), severe disability or death (mRS score 5-6). We tested for interaction to assess whether the effect of thrombectomy differed according to mismatch status.RESULTS: Three RCTs met the inclusion criteria, totaling 863 patients, of whom 113 (13%) had no perfusion mismatch (47% from LASTE). There was no significant interaction between mismatch status and EVT efficacy across any of the outcomes. In the mismatch subgroup, EVT significantly improved outcomes compared with medical therapy (mRS 0-3: OR=2.14, 95% CI 1.57 to 2.90; mRS score 0-2: OR=3.22, 95% CI 2.14 to 4.85; mRS score 5-6: OR=0.66, 95% CI 0.50 to 0.89; all I = 0%). In the no-mismatch subgroup, OR values were not significant for both mRS score 0-3 (OR=2.32, 95% CI 0.84 to 6.38) and mRS score 5-6 (OR=0.73, 95% CI 0.34 to 1.57); OR for mRS score 0-2 was neutral (OR=1.00, 95% CI 0.15 to 6.55).CONCLUSIONS: No interaction was found between mismatch status and EVT effect. However, in patients without mismatch, effect estimates were non-significant for EVT. Additional data are needed to better assess treatment benefit in this subgroup.

View details for DOI 10.1136/jnis-2025-024351

View details for PubMedID 41309233